Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries : 7th International Workshop, BrainLes 2021, Held in Conjunction with MICCAI 2021, Virtual Event, September 27, 2021, Revised Selected Papers, Part I / / edited by Alessandro Crimi, Spyridon Bakas
| Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries : 7th International Workshop, BrainLes 2021, Held in Conjunction with MICCAI 2021, Virtual Event, September 27, 2021, Revised Selected Papers, Part I / / edited by Alessandro Crimi, Spyridon Bakas |
| Autore | Crimi Alessandro |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham, : Springer Nature, 2022 |
| Descrizione fisica | 1 online resource (XXI, 489 p. 171 illus., 134 illus. in color.) |
| Disciplina |
006.37
616.8 |
| Collana | Lecture Notes in Computer Science |
| Soggetto topico |
Computer vision
Artificial intelligence Computer engineering Computer networks Application software Computer Vision Artificial Intelligence Computer Engineering and Networks Computer and Information Systems Applications Tumors cerebrals Lesions cerebrals |
| Soggetto genere / forma |
Congressos
Llibres electrònics |
| ISBN | 3-031-08999-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Supervoxel Merging towards Brain Tumor Segmentation -- Challenging Current Semi-Supervised Anomaly Segmentation Methods for Brain MRI -- Modeling multi-annotator uncertainty as multi-class segmentation problem -- Modeling multi-annotator uncertainty as multi-class segmentation problem -- Adaptive unsupervised learning with enhanced feature representation for intra-tumor partitioning and survival prediction for glioblastoma -- Predicting isocitrate dehydrogenase mutation status in glioma using structural brain networks and graph neural networks -- Optimization of Deep Learning based Brain Extraction in MRI for Low Resource Environments. Reciprocal Adversarial Learning for Brain Tumor Segmentation: A Solution to BraTS Challenge 2021 Segmentation Task -- Unet3D with Multiple Atrous Convolutions Attention Block for Brain Tumor Segmentation -- BRATS2021: exploring each sequence in multi-modal input for baseline U-net performance -- Automatic Brain Tumor Segmentation using Multi-scale Features and Attention Mechanism -- Simple and Fast Convolutional Neural Network applied to median cross sections for predicting the presence of MGMT promoter methylation in FLAIR MRI scans -- MSViT: Multi Scale Vision Transformer forBiomedical Image Segmentation -- Unsupervised Multimodal -- HarDNet-BTS: A Harmonic Shortcut Network for Brain Tumor Segmentation -- Multimodal Brain Tumor Segmentation Algorithm -- Swin UNETR: Swin Transformers for Semantic Segmentation of Brain Tumors in MRI Images -- Multi-plane UNet++ Ensemble for Glioblastoma Segmentation -- Multimodal Brain Tumor Segmentation using Modified UNet Architecture -- A video data based transfer learning approach for classification of MGMT status in brain tumor MR images -- Multimodal Brain Tumor Segmentation Using a 3D ResUNet in BraTS 2021 -- 3D MRI brain tumour segmentation with autoencoder regularization and Hausdorff distance loss function -- 3D CMM-Net with Deeper Encoder for Semantic Segmentation of Brain Tumors in BraTS2021 Challenge -- Cascaded training pipeline for 3D brain tumor segmentation -- nnU-Net with Region-based Training and Loss Ensembles for Brain Tumor Segmentation -- Brain Tumor Segmentation Using Attention Activated U-Net with Positive Mining -- Automatic segmentation of brain tumor using 3D convolutional neural networks -- Hierarchical and Global Modality Interaction for Brain Tumor Segmentation -- Ensemble Outperforms Single Models in Brain Tumor Segmentation -- Brain Tumor Segmentation using UNet-Context Encoding Network -- Ensemble CNN Networks for GBM Tumors Segmentation using Multi-parametric MRI. |
| Record Nr. | UNINA-9910585786203321 |
Crimi Alessandro
|
||
| Cham, : Springer Nature, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Concussions in athletics : from brain to behavior / / Semyon Slobounov, Wayne Sebastianelli
| Concussions in athletics : from brain to behavior / / Semyon Slobounov, Wayne Sebastianelli |
| Autore | Slobounov Semyon |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (463 pages) |
| Disciplina | 617.481044 |
| Soggetto topico |
Brain - Concussion
Sports injuries - Alternative treatment Lesions cerebrals Lesions esportives Medicina esportiva |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-75564-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910495181503321 |
|
Slobounov Semyon
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Detection of malingering during head injury litigation / / edited by Arthur MacNeill Horton and Cecil R. Reynolds
| Detection of malingering during head injury litigation / / edited by Arthur MacNeill Horton and Cecil R. Reynolds |
| Edizione | [3rd ed.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (366 pages) |
| Disciplina | 614.15 |
| Soggetto topico |
Malingering - Diagnosis
Lesions cerebrals Neuroradiologia Prevenció del delicte Simulació (Ciències de la salut) Processos |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-54656-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Assessment of Malingering and Falsification: Continuing to Push the Boundaries of Knowledge in Research and Clinical Practice -- 1 Limitations of Experience in Learning to Detect Malingering: Benefits of Augmenting Clinical Judgment with Formal Methods -- 2 Potential Benefits of Experience and Case Study -- 3 What Is the Nature of the Phenomenon We Are Trying to Measure? -- 3.1 Fundamental Components -- 3.2 Malingering Is a Hypothetical Construct -- 3.3 Distinguishing Between the Nature of Entities and Effective Measurement Strategies -- Key Questions About the Nature of Malingering -- 4 Clinical Needs and Research Agenda -- 4.1 Framing the Problem -- 4.2 Sources of Inaccuracy -- 4.3 Factors That Contribute to Case Difficulty and Ambiguity -- 4.4 Examiner Factors: Data Gathering and Selection of Procedures -- 4.5 Examiner Factors: Interpretive Approaches -- Confirmatory Bias and Premature Closure -- Illusory Correlation and Failure to Analyze Covariation -- Overconfidence -- Inappropriate Disjunctive or Conjunctive Strategies -- Data Combination -- Failure to Consider or Properly Apply Base Rates -- Misappraisal of Injury Severity -- 4.6 Examinee Factors -- The Skill of the Falsifier -- Preparation/"Coaching"/Incentives -- Overlap and Other Factors Compromising Effort -- Fluctuations or Changes in Conditions -- Complexity -- Less Well-Studied Conditions -- Absence of Hard Evidence -- Cultural Diversity -- Subtlety of Presentation/Relevant Differentials -- 5 Research Factors and Pressing Needs -- 5.1 Mixed Presentations: Injured and Malingering -- Variations in Conjoint Presentations -- Conjoint Presentations: Limits in Knowledge and Potential Consequences -- Implications of Conjoint Presentations for Clinical and Research.
Obstacles Created by Inter- and Intra-Individual Variation and the Need for Baseline Measurement -- Mixed Presentations: Some Additional Thoughts -- 5.2 The Extreme Group Problem -- Explanation of the EGP -- Possible Strategies for Addressing the EGP -- 5.3 Lack of Representative Samples -- 5.4 Base Rates: Some Research Priorities -- 5.5 Transparency -- 5.6 Data Combination and Incremental Validity -- 6 Caveats and Final Comments -- 6.1 Proposed Criteria for Malingering Detection -- 6.2 Labeling -- 6.3 Values Placed on Avoiding False-Positive Versus False-Negative Errors -- 6.4 Effort Is Not All or None -- 6.5 Extreme Results of Malingering Tests Are Often Not What They Seem -- 6.6 Response Set Measures on Questionnaires/Appraisal Of Informants -- 6.7 Potential Benefits of Adaptive Testing -- 6.8 Creative Use of Simulation Designs -- 6.9 Some Additional Thoughts on Research -- References -- Ethical Issues in Assessing Malingering in Head Injury Litigation -- 1 Introduction -- 2 Defining Malingering and Related Terms -- 3 Five Common Misconceptions of Validity Assessment -- 3.1 Litigants Who Intentionally Deceive Are "Bad" -- 3.2 The Base Rate for Litigant Deception Is Definitively Known -- 3.3 Litigant Deception Is of Trivial Significance -- 3.4 Litigant Deception Occurs in a Straightforward, Predictable Manner -- 3.5 Cutoff Scores on Validity Tests Are Extremely Accurate and Work Equally Well with all Litigant Populations -- 4 Twelve Important Ethical and Professional Issues in Forensic Neuropsychology -- 4.1 Professional Competence -- 4.2 Third-Party Requests for Service -- 4.3 Multiple Relationships and Conflicts of Interest -- 4.4 Informed Consent and Notification of Purpose -- 4.5 Bases for Assessments and Scientific and Professional Judgment -- 4.6 Use of Assessments and Interpreting Assessment Results. 4.7 Test Security and Release of Test Data -- 4.8 Contingency Fees -- 4.9 Impartiality and Bias -- 4.10 Third-Party Observers -- 4.11 Accuracy and Truthfulness in Public Statements -- 4.12 Addressing Ethical Misconduct -- 5 Conclusions -- References -- Cultural Aspects in Assessing Malingering Detection -- 1 Overview of the Chapter -- 2 Assessing Cognition in a Cross-Cultural Context -- 3 Cross-Cultural Effects on Malingering Detection -- 3.1 Efficacy of Stand-Alone Validity Indicators -- 3.2 Efficacy of Embedded Validity Indicators -- 4 Recommendations -- 4.1 Recommendations for the Individual Clinician -- Prior to the Assessment (Acquiring Cultural Competence, Examinee/Examiner Characteristics, and Use of Interpreters) -- During the Assessment (Testing Environment and Test Selection) -- Post Assessment (Interpretation and Report Writing) -- 4.2 General Recommendations -- Adequate Adaptation of Tests -- Need for Further Research and Test Development -- 5 Summary -- 6 Appendix (Case Report: Reaching Informed Decisions Regarding Malingering in a Cross-Cultural Context) -- References -- Neuroimaging and Invalid Neuropsychological Test Performance -- 1 Lesion Analysis: How Neuropathology May Influence SVT and PVT Interpretation -- 2 Neuroimaging Findings, SVT/PVT Results, and Forensic Application -- 3 Functional Neuroimaging and Experimental Paradigms of Malingering -- 4 Conclusions -- References -- Use of the Word Memory Test (WMT), Medical Symptom Validity Test (MSVT) and Nonverbal Medical Symptom Validity Test (NV-MSVT) in Assessment Following Head Injury -- 1 Word Memory Test -- 1.1 WMT Structure -- 1.2 Development of the WMT -- 1.3 Overwhelming Effects of Poor Task Engagement -- 1.4 WMT in Criminal Settings -- 1.5 Important GMIP Considerations -- 2 Medical Symptom Validity Test -- 3 Non-Verbal Medical Symptom Validity Test. 4 MSVT and NV-MSVT TBI Studies -- 5 The Concern about WMT False-Positives -- References -- Nonverbal Performance Validity Testing: Test of Memory Malingering (TOMM) -- 1 Introduction -- 1.1 TOMM Use with Children -- 1.2 TOMM Use with Different Groups -- Hearing Impaired -- Spanish Speaking -- 1.3 Differential Cut Score Results in Adults and Children and Adults Versus Children -- 1.4 TOMM Accuracy: Specificity/Sensitivity -- 2 Trial 1 Versus Both Trails -- 3 The TOMM First Ten Items Versus Full First Trial -- 3.1 TOMM Agreement with Other PVTs -- References -- Malingering of Executive Functioning in Head Injury Litigation -- 1 Methodological Issues -- 2 Performance-Based Executive Functioning Measures -- 2.1 Wisconsin Card Sorting Test -- 2.2 Category Test -- 2.3 Fluency Tasks -- 2.4 Stroop Tasks -- 2.5 Trail Making Test -- 2.6 Summary -- 3 Physiological Measures -- 4 Self-Reported Executive Functioning -- 5 Summary and Conclusions -- References -- Assessment of Malingering Among Head Injury Litigants with the MMPI-2, MMPI-2-RF, and MMPI-3 -- 1 Threats to Protocol Validity -- 2 MMPI-2 and MMPI-2-RF Validity Scales -- 2.1 MMPI-2 Validity Scales -- 2.2 MMPI-2-RF Validity Scales -- 2.3 Research on the MMPI-2-RF Overreporting Scales -- 2.4 MMPI-2-RF Interpretation Recommendations -- 3 Looking Ahead: The MMPI-3 -- 3.1 Development and Description of the MMPI-3 -- 3.2 MMPI-3 Substantive Scales -- 3.3 MMPI-3 Validity Scales -- 4 Chapter Summary -- References -- Performance Validity Assessment in Pediatric Evaluations -- 1 Development of Deception in Children -- 2 Is There Evidence That Children Engage in Deception in Clinical Settings? -- 3 How Good Are Adults at Deception Detection? -- 4 Brief Overview of PVTs in Youth -- 5 Free-Standing PVTs -- 5.1 Tests Specifically Developed for Pediatric Samples -- 5.2 Adult PVTs Researched for Use with Pediatric Samples. 6 Embedded PVTs -- 6.1 Tests Developed Specifically for Pediatric Samples -- 6.2 Embedded PVTs Originally Derived for Adult Samples -- 7 Important Groups to Consider -- 7.1 Attention Deficit Hyperactivity Disorder (ADHD) -- 7.2 Learning Disabilities (LD) -- 7.3 Sports-Related Concussions -- 7.4 mTBI (Without Litigation) -- 8 Potential Reasons for Failure -- 8.1 Legal Factors -- 8.2 Family Factors -- 8.3 Academic Difficulties -- 8.4 Social Factors -- 8.5 Sports Factors -- 8.6 Psychological Factors -- 9 PVT and mTBI Litigation -- 10 Concluding Thought -- References -- Explaining Performance and Symptom Validity Testing to the Trier of Fact -- 1 Scenario 1 -- 1.1 Cross-Examination By Plaintiff's Attorney of the Defense Neuropsychologist -- 1.2 Redirect by Defense Attorney -- 2 Scenario 2 -- 2.1 Cross-Examination by Plaintiff's Attorney of the Defense Neuropsychologist -- 2.2 Redirect by Defense Attorney -- 3 Scenario 3 -- 3.1 Cross-Examination by Plaintiff's Attorney of the Defense Neuropsychologist -- 3.2 Redirect by Defense Attorney -- 4 Scenario 4 -- 5 Scenario 5 -- 5.1 Cross-Examination by Plaintiff's Attorney of the Defense Neuropsychologist -- 6 Concluding Comment -- References -- Index. |
| Record Nr. | UNINA-9910495246003321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Management of Severe Traumatic Brain Injury : Evidence, Tricks, and Pitfalls / / edited by Terje Sundstrøm, Per-Olof Grände, Teemu Luoto, Christina Rosenlund, Johan Undén, Knut Gustav Wester
| Management of Severe Traumatic Brain Injury : Evidence, Tricks, and Pitfalls / / edited by Terje Sundstrøm, Per-Olof Grände, Teemu Luoto, Christina Rosenlund, Johan Undén, Knut Gustav Wester |
| Edizione | [2nd ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (xxxi, 689 pages) |
| Disciplina |
616.8046
617.4810446 |
| Soggetto topico |
Critical care medicine
Neurosurgery Radiology Anesthesiology Emergency medicine Rehabilitation Intensive / Critical Care Medicine Imaging / Radiology Emergency Medicine Lesions cerebrals Terapèutica Rehabilitació mèdica Cirurgia cerebral |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-39383-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Part I Traumatic brain injury as a public health problem -- Epidemiological aspects -- Challenges in low- and middle income countries -- Challenges in the elderly -- Challenges in children -- Biomechanics and prevention -- Part II Classification and assessment -- Pathophysiology of severe traumatic brain injury -- Classification of head injury -- Primary clinical assessment -- Part III Prehospital management -- Prehospital guidelines -- What the neurosurgeon and the trauma team want to know: what, who, when, and where? -- Transportation -- Part IV Admission, diagnostics and planning -- The trauma team concept -- Trauma protocol (ABCDE) -- Hospital response to mass casualty incidents -- Cervical spine injury -- Blast-induced injury -- Radiological evaluation of head trauma -- Radiological evaluation of cervical spine trauma -- Blood samples -- To treat or not to treat in the acute setting (withholding) and withdrawal of treatment -- Potential organ donor: organ donor management -- Ethical aspects and communication -- Part V Acute surgical treatment -- Basic trauma craniotomy -- Surgical management of traumatic intracranial haematomas -- Surgical management of penetrating brain injuries -- Decompressive craniectomy -- Skull fractures -- Vessel injuries -- Insertion of intracranial monitoring devices -- Maxillofacial fractures -- Considerations in patients with concomitant cervical spine injuries -- Soft tissue injuries -- Surgery outside neurosurgical units -- Planning of cranial and extracranial surgery in multitraumatised patients -- Part VI Perioperative anaesthesia -- Choice of anaesthesia, drugs and medications -- Blood pressure, CO2 and oxygen saturation -- Intracranial pressure reduction -- Part VII Monitoring in neurointensive care Secondary clinical assessment -- A wake-up test in the neurointensive care management of patients with severe TBI: pros and cons -- Intracranial pressure (ICP):Theoretical and practical aspects -- Brain tissue oxygen monitoring -- Monitoring microdialysis -- Jugular bulb measurements (SJVO2) -- Cerebral blood flow (CBF) and cerebral metabolic rate (CMR) -- Transcranial Doppler (TCD) -- Near infrared spectroscopy (NIRS) or cerebral oximetry -- Clinical Neurophysiology: Evoked Potentials -- Clinical Neurophysiology: Continous EEG Monitoring -- Imaging of severe traumatic brain injury in the neurointensive care unit -- Serum protein biomarkers in the management of severe traumatic brain injury -- Cardiopulmonary aspects -- Renal aspects -- Neuroendocrine aspects -- Part VIII Treatment in neurointensive care -- Guidelines for treatment of patients with severe traumatic brain injury -- The Lund therapy: a physiological approach -- Pharmacological neuroprotection -- Subacute surgery in neurointensive care -- Management of extracranial injuries -- CSF Drainage -- Hyperventilation -- Osmotherapy -- Barbiturates for ICP management -- Management of fluid and electrolyte disturbances -- Sedation: including pain treatment and withdrawal symptoms -- Nutrition -- Management of CNS-related infection -- Management of extracranial infections -- Temperature management -- Seizures -- Paroxysmal sympathetic hyperactivity -- Prophylaxis against venous thromboembolism -- Coagulopathy (bleeding tendency) -- Corticosteroids -- Management of acute psychiatric problems -- Part IX Rehabilitation and follow-up -- Rehabilitation after severe TBI -- Long-term follow-up -- Part X Outcome and prognosis -- General overview -- Somatic consequences -- Neuropsychiatric consequences -- Neuropsychological perspectives -- Neurosurgical challenges -- Minimally conscious and vegetative state -- Specific peadiatric concerns -- Socioeconomic consequences -- Subacute MR Imaging: Traumatic axonal injury, brain stem lesions and prognostic factors -- Neurodegeneration and dementia -- Part XI Research in severe TBI -- The neurointensive care unit as a platform for advanced clinical research -- Current state-of-the-art in neurotrauma research -- Index. |
| Record Nr. | UNINA-9910407728403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
